Expression of abnormal transcripts of the FHIT (Fragile Histidine Triad) gene in ovarian carcinoma
- 1 April 1998
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (5) , 745-749
- https://doi.org/10.1016/s0959-8049(97)10147-2
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 9 references indexed in Scilit:
- FHIT gene alterations in head and neck squamous cell carcinomas.Proceedings of the National Academy of Sciences, 1996
- The FHIT Gene at 3p14.2 Is Abnormal in Lung CancerCell, 1996
- The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract CancersCell, 1996
- Fhit, a Putative Tumor Suppressor in Humans, Is a Dinucleoside 5‘,5‘ ‘‘-P1,P3-Triphosphate HydrolaseBiochemistry, 1996
- Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma: correlation with tumour progression and nm23 gene expressionBritish Journal of Cancer, 1995
- Precise Localization of Aphidicolin-Induced Breakpoints on the Short Arm of Human Chromosome 3Genomics, 1995
- Allelic loss in ovarian cancerInternational Journal of Cancer, 1993
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Hereditary Renal-Cell Carcinoma Associated with a Chromosomal TranslocationNew England Journal of Medicine, 1979